Prognostic value of PD-L1 expression on tumor cells combined with CD8+ TIL density in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy

Prognostic value of PD-L1 expression on tumor cells combined with CD8+ TIL density in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy

Abstract Background/aim mmune checkpoint inhibition (CPI) has an increasing impact in the multimodal treatment of locally advanced non-small cell lung cancer (LA-NSCLC). Increasing evidence suggests treatment outcome depending on tumor cell PD-L1 expression. The purpose of this retrospective study w...

Full description

Bibliographic Details
Main Authors: Kathrin Gennen, Lukas Käsmann, Julian Taugner, Chukwuka Eze, Monika Karin, Olarn Roengvoraphoj, Jens Neumann, Amanda Tufman, Michael Orth, Simone Reu, Claus Belka, Farkhad Manapov
Format: Article
Language:English
Published: BMC 2020-01-01
Series:Radiation Oncology
Subjects:
TILs
PDL1
Chemoradiotherapy
Prognostic factors
Checkpoint inhibition
Online Access:https://doi.org/10.1186/s13014-019-1453-3

Internet

https://doi.org/10.1186/s13014-019-1453-3

Similar Items